14 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm
and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders
8-K
EX-1.1
jevjhekye8je1 3vryu
23 Jan 19
Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
5:05pm
10-K
b3c 22f8114j3ola2
31 Mar 15
Annual report
12:00am
424B4
x929jxsnftj
13 Feb 15
Prospectus supplement with pricing info
12:00am
S-1
eircib00fv
13 Jan 15
IPO registration
12:00am
DRS/A
66o6p8q33tfcctdipct
21 Nov 14
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next